Antenatal ambroxol effects on surfactant pool size and postnatal lung function in preterm ventilated rabbits.
Following maternal treatments with 50 mg/kg/day ambroxol for 2 or 3 days before delivery at 28 days gestation, preterm rabbits were ventilated to evaluate lung function. Subsequently, surfactant saturated phosphatidylcholine (SatPC) pool sizes were measured. One half of the ambroxol treated and control rabbits were given surfactant at delivery. Although surfactant improved lung function comparably for control and ambroxol treated rabbits, ambroxol treatments did not change ventilatory pressure requirements, compliances, or the recovery of intravascular labeled albumin in the lungs. Ambroxol treatments tended to increase lung volumes as evaluated by pressure-volume curves. The ambroxol treatments significantly increased lung tissue SatPC by 22%, but there were no changes in alveolar SatPC pool values. These results do not indicate a large effect of ambroxol on lung function in preterm rabbits.
Sun
B
B
Perinatal Laboratories, Harbor-UCLA Medical Center, UCLA School of Medicine, Torrance 90505.
Rider
E
E
Ikegami
M
M
Jobe
A
A
D000551:Ambroxol / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D005260:Female; D005325:Fetal Organ Maturity / Q000187:drug effects; D008168:Lung / Q000187:drug effects* / Q000196:embryology / Q000502:physiology; D008176:Lung Volume Measurements; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011663:Pulmonary Surfactants / Q000378:metabolism*; D011817:Rabbits
D011663:Pulmonary Surfactants; D000551:Ambroxol